Description
The component is coated on the stent. This coating consists of a blend of Sirolimus drug (the active ingredient) and biodegradable polymers (the inactive ingredient).
Sirolimus is a Macrocyclic lactone produced by Streptomyces hygroscopicus.
Auricle has proven drug release kinetics Initial Burst Release of 30%-40% Sirolimus in the first week followed by sustained release upto 90 days to maintain therapeutic Sirolimus drug concentration to optimize the anti-tissue proliferative action.
Reviews
There are no reviews yet.